The pooled OR was 14.32 (95% CI = 8.38–24.47, P < 0.00001), indicating that the PTEN loss rate in breast cancer was significantly higher than that in normal tissues (Figure 2A). This evidence concerns the gene PTEN and breast carcinoma.